{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:04:10Z","timestamp":1787061850289,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["SKLNMZZ202309"],"award-info":[{"award-number":["SKLNMZZ202309"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073280"],"award-info":[{"award-number":["82073280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273972"],"award-info":[{"award-number":["82273972"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130105"],"award-info":[{"award-number":["82130105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373911"],"award-info":[{"award-number":["82373911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330119"],"award-info":[{"award-number":["82330119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22337003"],"award-info":[{"award-number":["22337003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21907102"],"award-info":[{"award-number":["21907102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.apsb.2025.12.016","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:17:15Z","timestamp":1765844235000},"page":"1489-1509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of a small-molecule targeting PLAGL2 DNA-binding domain inhibits extracellular matrix formation and enhances lenvatinib sensitivity in hepatocellular carcinoma"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6916-3746","authenticated-orcid":false,"given":"Weiwei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanrui","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9163-3633","authenticated-orcid":false,"given":"Jingwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.12.016_bib1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.12.016_bib2","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hhepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.12.016_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","article-title":"Molecular pathogenesis and systemic therapies for hepatocellular carcinoma","volume":"3","author":"Llovet","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.apsb.2025.12.016_bib4","doi-asserted-by":"crossref","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2025.12.016_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1083\/jcb.201102147","article-title":"The extracellular matrix: a dynamic niche in cancer progression","volume":"196","author":"Lu","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2025.12.016_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","author":"Schrader","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.12.016_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-06991-9","article-title":"Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver","volume":"626","author":"Fan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.12.016_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2025.12.016_bib9","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.014647","article-title":"The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices","volume":"11","author":"Naba","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.apsb.2025.12.016_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ccr.2010.03.020","article-title":"PLAGL2 regulates wnt signaling to impede differentiation in neural stem cells and gliomas","volume":"17","author":"Zheng","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2025.12.016_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/leu.2010.301","article-title":"The transcription factor PlagL2 activates mpl transcription and signaling in hematopoietic progenitor and leukemia cells","volume":"25","author":"Landrette","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.apsb.2025.12.016_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7150\/thno.47800","article-title":"PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail 1","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.12.016_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.prp.2017.12.012","article-title":"MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer","volume":"214","author":"Xu","year":"2018","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.apsb.2025.12.016_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.onc.1207013","article-title":"Microarray screening for target genes of the proto-oncogene PLAG1","volume":"23","author":"Voz","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2025.12.016_bib15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/hep.31293","article-title":"PLAGL2\u2013EGFR\u2013HIF-1\/2\u03b1 signaling loop promotes HCC progression and erlotinib insensitivity","volume":"73","author":"Hu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.12.016_bib16","doi-asserted-by":"crossref","first-page":"14.30.1","DOI":"10.1002\/0471141755.ph1430s66","article-title":"The DEN and CCl4-induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma","volume":"66","author":"Uehara","year":"2014","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.apsb.2025.12.016_bib17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","article-title":"The epithelial\u2013mesenchymal plasticity landscape: principles of design and mechanisms of regulation","volume":"24","author":"Haerinck","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.apsb.2025.12.016_bib18","first-page":"7","article-title":"The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract","volume":"10","author":"Brzozowa","year":"2015","journal-title":"Przegl\u0105d Gastroenterol"},{"key":"10.1016\/j.apsb.2025.12.016_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/cells8050503","article-title":"Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis","volume":"8","author":"Krenkel","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2025.12.016_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000505318","article-title":"Moderate loss of the extracellular matrix proteoglycan lumican attenuates cardiac fibrosis in mice subjected to pressure overload","volume":"145","author":"Mohammadzadeh","year":"2020","journal-title":"Cardiology"},{"key":"10.1016\/j.apsb.2025.12.016_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000004","article-title":"Integrative analysis implicates the significance of m6A in the liver fibrosis of biliary atresia by regulating THY1","volume":"7","author":"Wang","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.apsb.2025.12.016_bib22","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1096\/fj.201901705R","article-title":"Tackling MARCKS\u2013PIP3 circuit attenuates fibroblast activation and fibrosis progression","volume":"33","author":"Yang","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2025.12.016_bib23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","article-title":"EGFR activation limits the response of liver cancer to lenvatinib","volume":"595","author":"Jin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.12.016_bib24","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3\u2013ABCB1 signaling in hepatocellular carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.016_bib25","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s12276-024-01223-0","article-title":"Stress-induced epinephrine promotes hepatocellular carcinoma progression via the USP10\u2013PLAGL2 signaling loop","volume":"56","author":"Wang","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.apsb.2025.12.016_bib26","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.12.016_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1055\/s-2004-814151","article-title":"The role of the IGF axis in hepatocarcinogenesis","volume":"35","author":"Scharf","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.apsb.2025.12.016_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1389557518666181025151608","article-title":"Insulin-like growth factor I receptor: a novel target for hepatocellular carcinoma gene therapy","volume":"19","author":"Wang","year":"2019","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.apsb.2025.12.016_bib29","article-title":"Hepatocyte deletion of IGF2 prevents DNA damage and tumor formation in hepatocellular carcinoma","volume":"9","author":"Kumar","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.12.016_bib30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/gutjnl-2015-309501","article-title":"Tumour initiating cells and IGF\/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma","volume":"66","author":"Tovar","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2025.12.016_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13046-015-0210-1","article-title":"Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1","volume":"34","author":"Lippolis","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.016_bib32","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1158\/1078-0432.CCR-08-2980","volume":"15","author":"Desbois-Mouthon","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.016_bib33","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/ijc.22221","article-title":"Impact of IGF-1R\/EGFR cross-talks on hepatoma cell sensitivity to gefitinib","volume":"119","author":"Desbois-Mouthon","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2025.12.016_bib34","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/1078-0432.CCR-17-3725","article-title":"The IGF2\/IR\/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma","volume":"24","author":"Vaquero","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.12.016_bib35","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2025.12.016_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cac2.12414","article-title":"Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib","volume":"43","author":"Eun","year":"2023","journal-title":"Cancer Commun"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352500824X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352500824X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:28:38Z","timestamp":1776040118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221138352500824X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S221138352500824X"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.016","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a small-molecule targeting PLAGL2 DNA-binding domain inhibits extracellular matrix formation and enhances lenvatinib sensitivity in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}